H.H. Hartgrink

3.2k total citations · 1 hit paper
39 papers, 1.8k citations indexed

About

H.H. Hartgrink is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Gastroenterology. According to data from OpenAlex, H.H. Hartgrink has authored 39 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 14 papers in Surgery and 12 papers in Gastroenterology. Recurrent topics in H.H. Hartgrink's work include Gastric Cancer Management and Outcomes (21 papers), Metastasis and carcinoma case studies (13 papers) and Gastrointestinal Tumor Research and Treatment (12 papers). H.H. Hartgrink is often cited by papers focused on Gastric Cancer Management and Outcomes (21 papers), Metastasis and carcinoma case studies (13 papers) and Gastrointestinal Tumor Research and Treatment (12 papers). H.H. Hartgrink collaborates with scholars based in Netherlands, Sweden and Denmark. H.H. Hartgrink's co-authors include Hein Putter, Elma Meershoek‐Klein Kranenbarg, Cornelis J.�H. van de Velde, Johannes J. Bonenkamp, C.J.H. van de Velde, John Th. M. Plukker, C. W. Taat, S. Meijer, H. Obertop and Mitsuru Sasako and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

H.H. Hartgrink

37 papers receiving 1.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Extended Lymph Node Dissection for Gastric Cancer: Who May Benefit? Final Results of the Randomized Dutch Gastric Cancer Group Trial

2004 671 citations H.H. Hartgrink, C.J.H. van de Velde et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H.H. Hartgrink Netherlands	19	1.3k	876	677	347	162	39	1.8k
Giovanni Persico Italy	22	526 0.4×	997 1.1×	260 0.4×	325 0.9×	156 1.0×	66	1.5k
Leonardo Solaini Italy	21	714 0.5×	809 0.9×	204 0.3×	495 1.4×	151 0.9×	81	1.4k
Koshi Kumagai Japan	31	2.1k 1.6×	1.6k 1.9×	830 1.2×	720 2.1×	31 0.2×	141	2.8k
Isaac Raijman United States	28	1.7k 1.2×	2.2k 2.5×	392 0.6×	1.3k 3.6×	67 0.4×	122	2.6k
Hua‐Long Zheng China	15	721 0.5×	466 0.5×	338 0.5×	278 0.8×	22 0.1×	77	1.1k
Yuichi Kojima Japan	18	322 0.2×	552 0.6×	332 0.5×	84 0.2×	140 0.9×	102	1.1k
Takeki Sugimoto Japan	18	371 0.3×	528 0.6×	113 0.2×	337 1.0×	159 1.0×	84	1.1k
Ioannis Hatzaras United States	20	783 0.6×	869 1.0×	138 0.2×	692 2.0×	73 0.5×	53	1.4k
Harushi Osugi Japan	27	1.8k 1.3×	1.8k 2.0×	566 0.8×	347 1.0×	40 0.2×	154	2.5k
Cho Hyun Park South Korea	30	2.5k 1.9×	1.6k 1.9×	1.1k 1.6×	791 2.3×	33 0.2×	119	3.3k

Countries citing papers authored by H.H. Hartgrink

Since Specialization

Citations

This map shows the geographic impact of H.H. Hartgrink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.H. Hartgrink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.H. Hartgrink more than expected).

Fields of papers citing papers by H.H. Hartgrink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.H. Hartgrink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.H. Hartgrink. The network helps show where H.H. Hartgrink may publish in the future.

Co-authorship network of co-authors of H.H. Hartgrink

This figure shows the co-authorship network connecting the top 25 collaborators of H.H. Hartgrink. A scholar is included among the top collaborators of H.H. Hartgrink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.H. Hartgrink. H.H. Hartgrink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fiocco, Marta, Jan F. Ubbels, Lukas B. Been, et al.. (2025). Pandemic driven preoperative moderate hypofractionated radiotherapy for soft tissue sarcomas. European Journal of Cancer. 217. 115234–115234. 1 indexed citations

Wiklund, K, Fredrik Pontén, P Lind, et al.. (2023). Effect of preoperative chemotherapy on the histopathological classification of gastric cancer. Gastric Cancer. 27(1). 102–109. 1 indexed citations

Görgeç, Burak, H.H. Hartgrink, Dirk J. Grünhagen, et al.. (2023). Clinical Added Value of Gadoxetic Acid Enhanced Liver MRI in Patients Scheduled for Local Therapy of Colorectal Liver Metastases Based on CT Imaging (CAMINO). HPB. 25. S194–S194.

Wilk, Berend J. van der, Ben M. Eyck, Bas P. L. Wijnhoven, et al.. (2023). LBA75 Neoadjuvant chemoradiotherapy followed by surgery versus active surveillance for oesophageal cancer (SANO-trial): A phase-III stepped-wedge cluster randomised trial. Annals of Oncology. 34. S1317–S1317. 26 indexed citations

Henegouwen, Mark I. van Berge, Hanneke W.M. van Laarhoven, Jessy Joy van Kleef, et al.. (2021). Postoperative Complications and Long-Term Quality of Life After Multimodality Treatment for Esophageal Cancer: An Analysis of the Prospective Observational Cohort Study of Esophageal-Gastric Cancer Patients (POCOP). Annals of Surgical Oncology. 28(12). 7259–7276. 19 indexed citations

Bloem, J. L., Judith V.M.G. Bovée, Michiel A. J. van de Sande, et al.. (2021). Personalising sarcoma care using quantitative multimodality imaging for response assessment. Clinical Radiology. 76(4). 313.e1–313.e13. 5 indexed citations

Hartgrink, H.H., Wobbe O. de Steur, Johan L. Dikken, et al.. (2018). Impact of upfront randomization for postoperative treatment on quality of surgery in the CRITICS gastric cancer trial. Gastric Cancer. 22(2). 369–376. 5 indexed citations

Bosscha, Koop, et al.. (2018). Morbidity and mortality according to age following gastrectomy for gastric cancer. British journal of surgery. 105(9). 1163–1170. 34 indexed citations

Dikken, Johan L., H.H. Hartgrink, Wobbe O. de Steur, et al.. (2018). North European comparison of treatment strategy and survival in older patients with resectable gastric cancer: A EURECCA upper gastrointestinal group analysis. European Journal of Surgical Oncology. 44(12). 1982–1989. 5 indexed citations

10.

Hartgrink, H.H., Johan L. Dikken, Wobbe O. de Steur, et al.. (2018). Surgical morbidity and mortality after neoadjuvant chemotherapy in the CRITICS gastric cancer trial. European Journal of Surgical Oncology. 44(5). 613–619. 38 indexed citations

11.

Putten, Margreet van, V.E.P.P. Lemmens, Jan H.M.B. Stoot, et al.. (2018). Overall survival before and after centralization of gastric cancer surgery in the Netherlands. British journal of surgery. 105(13). 1807–1815. 73 indexed citations

12.

Handgraaf, Henricus J.M., Leonora S. F. Boogerd, Diederik J. Höppener, et al.. (2017). Long-term follow-up after near-infrared fluorescence-guided resection of colorectal liver metastases: A retrospective multicenter analysis. European Journal of Surgical Oncology. 43(8). 1463–1471. 69 indexed citations

13.

Bastiaannet, Esther, Ruth E. Langley, Whay Kuang Chia, et al.. (2017). Effect of low-dose aspirin use on survival of patients with gastrointestinal malignancies; an observational study. British Journal of Cancer. 116(3). 405–413. 31 indexed citations

14.

Seesing, Maarten F. J., R. Tielen, Richard van Hillegersberg, et al.. (2016). Resection of liver metastases in patients with gastrointestinal stromal tumors in the imatinib era: A nationwide retrospective study. European Journal of Surgical Oncology. 42(9). 1407–1413. 30 indexed citations

15.

Tielen, R., Cornelis Verhoef, Frits van Coevorden, et al.. (2012). Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib. European Journal of Surgical Oncology. 39(2). 150–155. 55 indexed citations

16.

Vorst, Joost R. van der, Merlijn Hutteman, Boudewijn E. Schaafsma, et al.. (2011). 2500 POSTER Identification and Image-guided Resection of Occult Superficial Liver Metastases Using Indocyanine Green and Near-infrared Fluorescence Imaging. European Journal of Cancer. 47. S217–S217. 1 indexed citations

17.

Iersel, L.B.J. van, Miriam Koopman, Cornelis J.�H. van de Velde, et al.. (2010). Management of isolated nonresectable liver metastases in colorectal cancer patients: a case–control study of isolated hepatic perfusion with melphalan versus systemic chemotherapy. Annals of Oncology. 21(8). 1662–1667. 17 indexed citations

18.

Iersel, L.B.J. van, Hans Gelderblom, Alexander L. Vahrmeijer, et al.. (2008). Isolated hepatic melphalan perfusion of colorectal liver metastases: outcome and prognostic factors in 154 patients. Annals of Oncology. 19(6). 1127–1134. 38 indexed citations

19.

Steenvoorde, Pascal, et al.. (2006). Necrotizing Soft Tissue Infection of the Thigh: Consider an Abdominal Cause. World Journal of Surgery. 30(10). 1836–1842. 4 indexed citations

20.

Hartgrink, H.H., et al.. (2001). Primary pheochromocytoma extending into the right atrium: report of a case and review of the literature. European Journal of Surgical Oncology. 27(1). 115–119. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact